The objective
of this research study is to explore the potential of gene therapy as a
treatment for colour vision deficiencies, to improve colour discrimination and
perception in affected individuals. Gene therapy has emerged as a promising
approach for treating colour vision deficiencies, including red-green colour
blindness. Gene therapy involves the delivery of therapeutic genes into target
cells to correct genetic abnormalities and restore normal cellular function.
Cell sensitivity, and improved colour discrimination in animal models.
Furthermore, early clinical trials have reported encouraging outcomes,
indicating the potential effectiveness and safety of gene therapy in humans.
This study provides an overview of the advancements and challenges in gene
therapy for colour vision. It highlights the genetic basis of colour blindness,
the various gene therapy strategies employed, and the outcomes of preclinical
and clinical studies. Gene therapy holds promise as a potential therapeutic
avenue for addressing colour vision deficiencies, and ongoing research and
clinical trials will continue to shed light on its effectiveness, safety, and
long-term outcomes.
Author
(s) Details
Mrs.
Priyanka Patnaik (Associate Professor)
Acharya Institute of Allied Health Sciences,
Bengaluru, India.
Please see the book:- https://doi.org/10.9734/bpi/rudhr/v9/188
No comments:
Post a Comment